A comprehensive view of Relievant Medsystems. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Health Care Sector Market Intelligence Service.

Recent Articles

sample of recent headlines, press releases and get more..

Boston Scientific finalizes acquisition of Relievant Medsystems, provider of the only FDA-cleared therapy for chronic low back pain; Relievant’s Nerve Ablation System will enhance Boston Scientific's chronic pain portfolio
Published: November 20, 2023 by Medical Buyer
Boston Scientific closes acquisition of Relievant Medsystems; Relievant offers the only FDA-cleared Intracept intraosseous nerve ablation system to treat vertebrogenic pain, a form of chronic low back pain
Published: November 17, 2023 by Boston Scientific Corp.
Boston Scientific to acquire neuromodulation firm Relievant Medsystems for US$850M, boosting its chronic back pain treatment business and complementing its existing technologies; the acquisition is expected to close in H1 2024
Published: September 19, 2023 by MedTech Dive

Ask us about our Health Care Sector market view

Trending Chart

Interactive chart with headline count